Skip to main content
SpringerLink
Log in

Global Health Partnerships between Multinationals and BRICA: A Planting Strategy

  • Chapter
Global Health Partnerships

  • 129 Accesses

Abstract

Global health challenges have taken a severe toll on economic development in resource-rich as well as resource-poor countries. Yet they have also brought about a unique opportunity to rethink a global strategy for a new kind of partnership between the large multinational pharmaceutical companies and the BRICA stakeholders for a win-win situation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • A&A Contract Customs and Brokers (26 August 2008) “FDA to set up food and drug offices in China.” Available at http://www.irishtimes.com/newspaper/health/2008/082/1219679936900.html

  • Angell, M. (2004) The Truth about the Drug Companies. New York: Random House.

    Google Scholar 

  • Barnes, C. (7 November 2007) “New counterfeit report highlights worrying trends.” Available at: http://www.outsourcing-pharma.com/news/ng.asp?n=81178-oecd-counterfeit-drug-supply-chain

    Google Scholar 

  • BNET (2005) “Chirac proposes global tax; Gates bets against dollar.” Available at: http://findarticles.com/p/articles/mi_m0JZS/is_4_21/ai_n25105111

  • Bogdanich, W. (12 December 2007a) “Agreement with China to regulate some drugs.” Available at: http://www.nytimes.com/2007/12/12/business/worldbusiness/12safetyhtml?_r=1&oref=slogin

    Google Scholar 

  • Bogdanich, W. (17 December, 2007b) “Counterfeit drugs’ path eased by free trade zones.” New York Times. Available at: http://www.nytimes.com/2007/12/17/world/middleeast/17freezone.html?_r=1&partner=rssnyt&emc=rss&oref=slogin

  • Business Insights (August 2006) “Pharmaceutical growth opportunities in Brazil, Russia, India and China: Healthcare reform, market dynamics and key players.” Available at: http://www.piribo.com/publications/country/latin_america/ brazil/pharmaceutical_growth_opportunities_brazil_russia_india_china.html

  • Caines, K. (2004) “GHP study paper: Global health partnerships and neglected diseases.” DFID Health Resource Centre. Available at: http://www.ohchr.org/english/issues/development/docs/WHO_4.pdf

    Google Scholar 

  • CAPTH (2008) “Center for policy analysis of trade and health: Thailand’s compulsory licenses for medicines.” Available at: http://www.cpath.org/id27.html

  • CBS News (23 September 2005) “Brazil’s drug copying industry.” Available at: http://www.cbsnews.com/stories/2003/09/25/health/main575168.shtml

  • China Knowledge (2008) Available at: http://www.chinaknowledge.com/; or http://www.aacb.com/news/press.asp?id=3819).

  • Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D. and White, N. J. (2005) “The global threat of counterfeit drugs: Why industry and governments must communicate the dangers.” PLoS Med, vol. 2, no. 4. Available at: e100 doi:10.1371/journal.pmed.0020100 or http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020100&ct=1

    Google Scholar 

  • CPTECH (2007) “The medical innovation prize fund.” Available at: http://www.cptech.org/ip/health/prizefund/other-articles.html

    Google Scholar 

  • DNDi (2008) “GlaxoSmithKline, Drugs for Neglected Diseases Initiative to Collaborate on Research Projects to Meet Public Health Needs in the Developing World.” Available at: http://www.dndi.org/cms/public_html/insidearticleListing.asp?CategoryId=166&SubCategoryId=167&ArticleId=463&TemplateId=1)

  • Ebisch, R. (March 2005) “Prescription for change.” Teradata Magazine on-line. Available at: http://www.teradata.com/t/page/131951/

  • EuroNews (24 May 2008) “Doce países latinoamericanos se integran en la UNASUR.” Available at: http://www.euronews.net/index.php?page=info&article=489167&lng=5

  • FierceBiotech (6 December 2007) “Say goodbye to Big Pharma’s gilded age.” Available at: http://www.fiercepharma.com/story/say-goodbye-big-pharmas-gilded-age/2007-12-06

  • Grace, C. (2004) “GHP study paper: Global health partnership impact on commodity pricing and security.” DFID Health Resource Centre. Available at: http://www.ohchr.org/english/issues/development/docs/WHO_3.pdf

    Google Scholar 

  • IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) (2008) “Glivec International Patient Assistance Program.” Available at: http://www.ifpma.org/index.php?id=302

    Google Scholar 

  • IMS (8 March 2007a) “IMS Reports U.S. Prescription Sales Jump 8.3 Percent in 2006, to $274.9 Billion.” Available at: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_8041546500.html

  • IMS (August 2007b) “IMS health reports global pharmaceutical market grew 7.0 percent in 2006, to $643 billion.” Available at: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6025_3665_44771558,00.html

  • International Narcotics Control Board (2 March 2007). “International Narcotics Control Board 2006 Report.” Vienna: INCB.

    Google Scholar 

  • Kermani, F. (October 2005) “Contract Farma.” Available at: http://www.contractpharma.com/articles/2005/10/regional-roundup-brazil

    Google Scholar 

  • Knowledge Ecology International (2008) “Prizes to stimulate innovation.” Available at: http://www.keionline.org/index.php?option=com_content&task=view&id=4

  • Laverty, B. Vice President (10 December 2007) Communications, Malaria Initiatives, Novartis: Commentary On Coartem Partnership. Philadelphia, PA: University of the Sciences.

    Google Scholar 

  • Morris, J. and Stevens, P. (2006) Counterfeit Medicines in Less Developed Countries: Problems and Solutions. London: International Policy Network.

    Google Scholar 

  • Mukhopadhyay R. (1 April 2007) “The hunt for counterfeit medicine.” Analytical Chemistry. Available at: http://pubs.acs.org/subscribe/journals/ancham/79/i07/pdf/0407feature_mukhopadhyay.pdf

  • National Public Radio (6 October 2006) “US faces flu vaccine shortage.” Available at: http://www.npr.org/templates/story/storyphp?storyId=4073505

    Google Scholar 

  • New Scientist (25 February 2006a) “Global task force to target fake-drug peddlers.” Available at: http://www.newscientist.com/channel/opinion/mg18925403.700-global-task-force-to-target-fakedrug-peddlers.html

  • New Scientist (8 September 2006b) “The medicines that could kill millions.” Available at: http://www.newscientist.com/channel/health/mg19125683.900-the-medicines-that-could-kill-millions.html

  • New Scientist Tech (3 February 2007) “Lasers spot fake drugs in the packet.” Available at: http://www.newscientist.com/article.ns?id=mg19325896.100

  • New Technology for Malaria (2006) “Artemisinin derivatives.” Available at: http://www.artemisininproject.org/Malaria/artemisinins.htm

  • New York Times (3 March 2004) “A shortage of meningitis vaccine.” Available at: http://querynytimes.com/gst/fullpage.html?res=9901E4DE153FF930A35750C0A9629C8B63

  • New York Times (22 April 2008) “FDA identifies tainted heparin in 11 countries.” Available at: http://www.starnewsonline.com/article/20080422/ZNYT04/804220313/0/NEWS

  • News-Medical.Net (2008) “New method to detect fake tamiflu.” Available at: http://www.news-medical.net/?id=37079

  • PAHO (2003) “An update on quality assurance and procurement through WHO for improving access to artemisinin-based combination treatments (ACTs) for malaria.” Available at: http://www.paho.org/English/AD/DPC/CD/mal-acts-update-7-03.htm

  • PLOS (2003) “Companies that have warned.” Available at: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020100&ct=1

  • PRAVDA (2008). “TATA motors makes Mercedes for the poor.” Available at: http://english.pravda.ru/business/companies/10-01-2008/103346-tata-nano-0

  • Research and Markets (March 2006) “The image of the pharmaceutical industry in Brazil: Challenges and opportunities.” Available at: http://www.researchandmarkets.com/reportinfo.asp?report_id=335963

  • RSC (2007) “Forging ahead of the counterfeiters.” Available at: http://www.rsc.org/chemistryworld/News/2007/October/29100701.asp

  • Sherma, J. (2007) “Analysis of counterfeit drugs by thin layer chromatography.” Available at: http://www.us.edu.pl/uniwersytet/jednostki/wydzialy/chemia/acta/ac19/zrodla/01_AC19.pdf

    Google Scholar 

  • Silva, R. (6 March 2008) Commentary on Brazil’s Pharmaceutical Industry. Philadelphia, PA: University of Sciences in Philadelphia.

    Google Scholar 

  • Sturchio, J. L. (2001) “The case of ivermectin: Lessons and implications for improving access to care and treatment in developing Countries.” Journal of Community Eye Health, vol. 14, no. 38, pp. 22–3. Available at: http://www.cehjournal.org/0953-6833/14/jceh_14_38_022.html

    Google Scholar 

  • TATA (2008a) “A tradition of trust.” Available at: http://www.tata.com/0_our_commitment/community_initiatives/tata_trusts/overview.htm

  • TATA (2008b) “About us.” Available at: http://www.tata.com/0_about_us/history/index.htm

  • TATA (2008c) “Good to great.” Available at: http://www.tata.com/

  • The Times of India (2008) “TATA acquires Jaguar, Land Rover for 2.3 billion.” Available at: http://timesofindia.indiatimes.com/Tata_acquires_Jaguar_Land_Rover_for_23_bn/articleshow/2902216.cms

  • TOPNEWS (12 February 2008) “Fake anti-malarial drugs investigation highlights threat to global health.” Available at: http://www.topnews.in/health/fake-anti-malarial-drugs-investigation-highlights-threat-global-health-21020)

  • Wikipedia (2007) “Pharmaceutical companies.” Available at: http://en.wikipedia.org/wiki/Pharmaceutical_companies

  • Wikipedia (2008) “TATA group.” Available at: http://en.wikipedia.org/wiki/Tata_Group

  • World Health Assembly Executive Board (24 February 2005) “World Health Organization Commission on Intellectual Property, Innovation and Health.” Available at: www.who.int/intellectualproperty/en/

    Google Scholar 

  • World Health Organization (2003) “Substandard and counterfeited medicines.” Available at: http://www.who.int/mediacentre/factsheets/2003/fs275/en/

    Google Scholar 

  • World Health Organization (2008) “African Programme for Onchocerciasis Control.” Available at: http://www.who.int/blindness/partnerships/APOC/en/

    Google Scholar 

  • World Journal (24 May 2008) “FDA awaits China’s permission to set offices in Beijing, Shanghai and Kwanzhou” (FDA jing huei hu ban shih tsu, tai chung kuo heh dwen), B-7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of the Sciences, Philadelphia, USA

    Mei-Ling Wang (Associate Professor)

Authors
  1. Mei-Ling Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2009 Mei-Ling Wang

About this chapter

Cite this chapter

Wang, ML. (2009). Global Health Partnerships between Multinationals and BRICA: A Planting Strategy. In: Global Health Partnerships. Palgrave Macmillan, London. https://doi.org/10.1057/9780230582873_4

Download citation

Publish with us

Policies and ethics

Search

Navigation